Integrative analysis of transcriptomic and epigenomic data to reveal regulation patterns for BMD variation

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Zhang, Ji Gang ^a,b   Tan, Li Jun ^c   Xu, Chao ^a,b   He, Hao ^a,b   Tian, Qing ^a,b   Zhou, Yu ^a,b   Qiu, Chuan ^a,b   Chen, Xiang Ding ^c   Deng, Hong Wen ^a,b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 34A; MICRORNA 4291; UNCLASSIFIED DRUG; MESSENGER RNA; TRANSCRIPTOME;

ADULT; AKT1 GENE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FAM50A GENE; FEMALE; FLT3 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC REGULATION; HIP; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; STAT3 GENE; STAT5A GENE; TMEM55B GENE; TRANSCRIPTOMICS; ZNF473 GENE; BIOLOGY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC VARIATION; GENETICS; OSTEOPOROSIS; PROCEDURES; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADULT; BONE DENSITY; COMPUTATIONAL BIOLOGY; EPIGENOMICS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC VARIATION; HUMANS; MICRORNAS; OSTEOPOROSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTOME; YOUNG ADULT;

EID: 84946566586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138524     Document Type: Article

References (53)

1. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332(12):767-73. Epub 1995/03/23. doi: 10.1056/NEJM199503233321202 PMID: 7862179.
2. Recker RR, Deng HW. Role of genetics in osteoporosis. Endocrine. 2002; 17(1):55-66. Epub 2002/05/ 17. doi: ENDO:17:1:55. PMID: 12014706.
3. Juran BD, Lazaridis KN. Genomics in the post-GWAS era. Semin Liver Dis. 2011; 31(2):215-22. Epub 2011/05/04. doi: 10.1055/s-0031-1276641 PMID: 21538286; PubMed Central PMCID: PMC3285545.
4. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011; 12(8):529-41. Epub 2011/07/13. doi: 10.1038/nrg3000 PMID: 21747404.
5. Deng FY, Lei SF, Zhang Y, Zhang YL, Zheng YP, Zhang LS, et al. Peripheral blood monocyteexpressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics. 2011; 10(11):M111 011700. Epub 2011/08/06. doi: 10.1074/mcp.M111.011700 PMID: 21817168; PubMed Central PMCID: PMC3226411.
6. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009; 461 (7261):218-23. Epub 2009/09/11. doi: 10.1038/nature08454 PMID: 19741703.
7. Farber CR, Lusis AJ. Future of osteoporosis genetics: enhancing genome-wide association studies. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2009; 24(12):1937-42. doi: 10.1359/jbmr.091101 PMID: 19888896; PubMed Central PMCID: PMC3626446.
8. Farber CR. Identification of a gene module associated with BMD through the integration of network analysis and genome-wide association data. J Bone Miner Res. 2010; 25(11):2359-67. Epub 2010/05/ 26. doi: 10.1002/jbmr.138 PMID: 20499364.
9. Leung R, Cuddy K, Wang Y, Rommens J, Glogauer M. Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis. Blood. 2011; 117(6):2044-53. Epub 2010/11/19. doi: 10.1182/blood-2010-05-282574 PMID: 21084708.
10. Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, Recker RR, et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem. 2005; 280(32):29011-6. PMID: 15965235
11. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 1996; 137(9):4058-60. PMID: 8756585
12. Higuchi S, Tabata N, Tajima M, Ito M, Tsurudome M, Sudo A, et al. Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies. J Bone Miner Res. 1998; 13(1):44-9. PMID: 9443789
13. Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009; 458(7237):524-8. Epub 2009/02/11. doi: 10.1038/nature07713 PMID: 19204730; PubMed Central PMCID: PMC2785034.
14. Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. Journal of Experimental Medicine. 2010; 207(13):2793-8. Epub 2010/12/08. doi: 10.1084/jem.20101474 PMID: 21135136; PubMed Central PMCID: PMC3005230.
15. Jevon M, Hirayama T, Brown MA, Wass JA, Sabokbar A, Ostelere S, et al. Osteoclast formation from circulating precursors in osteoporosis. Scandinavian journal of rheumatology. 2003; 32(2):95-100. PMID: 12737328.
16. Reddy SV, Menaa C, Singer FR, Demulder A, Roodman GD. Cell biology of Paget's disease. J Bone Miner Res. 1999; 14 Suppl 2:3-8. PMID: 10510206.
17. Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, De Vernejoul MC. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab. 1993; 77(6):1648-53. PMID: 8263153
18. Zhou Y, Deng HW, Shen H. Circulating monocytes: an appropriate model for bone-related study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015. doi: 10.1007/s00198- 015-3250-7 PMID: 26194495.
19. Lienhard M, Grimm C, Morkel M, Herwig R, Chavez L. MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics. 2014; 30 (2):284-6. doi: 10.1093/bioinformatics/btt650 PMID: 24227674; PubMed Central PMCID: PMC3892689.
20. Tyekucheva S, Marchionni L, Karchin R, Parmigiani G. Integrating diverse genomic data using gene sets. Genome Biol. 2011; 12(10):R105. Epub 2011/10/25. doi: 10.1186/gb-2011-12-10-r105 PMID: 22018358; PubMed Central PMCID: PMC3333775.
21. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100(16):9440-5. Epub 2003/07/29. doi: 10.1073/pnas.1530509100 PMID: 12883005; PubMed Central PMCID: PMC170937.
22. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS, et al. A novel signaling pathway impact analysis. Bioinformatics. 2009; 25(1):75-82. Epub 2008/11/08. doi: 10.1093/bioinformatics/btn577 PMID: 18990722; PubMed Central PMCID: PMC2732297.
23. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011; 39(Database issue):D561-8. Epub 2010/11/04. doi: 10.1093/nar/gkq973 PMID: 21045058; PubMed Central PMCID: PMC3013807.
24. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, et al. Genome-wide metaanalysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012; 44(5):491-501. Epub 2012/04/17. doi: 10.1038/ng.2249 PMID: 22504420; PubMed Central PMCID: PMC3338864.
25. Sun GJ, Guo T, Chen Y, Xu B, Guo JH, Zhao JN. Significant pathways detection in osteoporosis based on the bibliometric network. Eur Rev Med Pharmacol Sci. 2013; 17(1):1-7. Epub 2013/01/19. PMID: 23329517.
26. Li B, Wang Y, Liu Y, Ma J, Li Y. Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine. 2013; 43(1):136-46. Epub 2012/07/24. doi: 10.1007/ s12020-012-9757-1 PMID: 22820932.
27. Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Tateda S, Yahata K, et al. The role of mTOR signaling pathway in spinal cord injury. Cell Cycle. 2012; 11(17):3175-9. Epub 2012/08/17. doi: 10.4161/cc. 21262 PMID: 22895182; PubMed Central PMCID: PMC3466516.
28. Shinohara M, Nakamura M, Masuda H, Hirose J, Kadono Y, Iwasawa M, et al. Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport. J Bone Miner Res. 2012; 27(12):2464-75. Epub 2012/07/19. doi: 10.1002/jbmr.1703 PMID: 22806988.
29. Mukherjee A, Rotwein P. Selective signaling by Akt1 controls osteoblast differentiation and osteoblastmediated osteoclast development. Mol Cell Biol. 2012; 32(2):490-500. Epub 2011/11/09. doi: 10.1128/ MCB.06361-11 PMID: 22064480; PubMed Central PMCID: PMC3255772.
30. Hirose J, Masuda H, Tokuyama N, Omata Y, Matsumoto T, Yasui T, et al. Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5-Dusp axis in the osteoclast. J Exp Med. 2014; 211 (1):153-63. Epub 2013/12/25. doi: 10.1084/jem.20130538 PMID: 24367002; PubMed Central PMCID: PMC3892975.
31. Laulederkind SJ, Liu W, Smith JR, Hayman GT, Wang SJ, Nigam R, et al. PhenoMiner: quantitative phenotype curation at the rat genome database. Database (Oxford). 2013; 2013:bat015. Epub 2013/ 04/23. doi: 10.1093/database/bat015 PMID: 23603846; PubMed Central PMCID: PMC3630803.
32. Phornphutkul C, Wu KY, Auyeung V, Chen Q, Gruppuso PA. mTOR signaling contributes to chondrocyte differentiation. Developmental dynamics: an official publication of the American Association of Anatomists. 2008; 237(3):702-12. doi: 10.1002/dvdy.21464 PMID: 18265001; PubMed Central PMCID: PMC2768549.
33. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH. Bone remodelling at a glance. Journal of cell science. 2011; 124(Pt 7):991-8. doi: 10.1242/jcs.063032 PMID: 21402872.
34. Pramojanee SN, Phimphilai M, Chattipakorn N, Chattipakorn SC. Possible roles of insulin signaling in osteoblasts. Endocrine research. 2014. doi: 10.3109/07435800.2013.879168 PMID: 24679227.
35. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010; 142(2):296-308. doi: 10.1016/j.cell. 2010.06.003 PMID: 20655470; PubMed Central PMCID: PMC2910411.
36. Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, Wagner KU. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol. 2010; 30(12):2957-70. Epub 2010/04/14. doi: 10.1128/MCB.00851-09 PMID: 20385773; PubMed Central PMCID: PMC2876679.
37. Su Z, Xia J, Zhao Z. Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome. BMC genomics. 2011; 12 Suppl 5: S15. doi: 10.1186/1471-2164-12-S5-S15 PMID: 22369656; PubMed Central PMCID: PMC3287497.
38. Zhang Z, Welte T, Troiano N, Maher SE, Fu XY, Bothwell AL. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice. Biochem Biophys Res Commun. 2005; 328(3):800-7. Epub 2005/02/08. PMID: 15694417.
39. Li C, Zhao J, Sun L, Yao Z, Liu R, Huang J, et al. RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis. Biochemical and biophysical research communications. 2012; 429(3-4):156-62. doi: 10.1016/j.bbrc.2012.10.122 PMID: 23142594.
40. Li CH, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, et al. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochemical and biophysical research communications. 2013; 435(4):533-9. doi: 10.1016/j.bbrc.2013.04.084 PMID: 23665018.
41. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007; 282(28):20059-63. Epub 2007/05/16. doi: R700016200 doi: 10.1074/jbc.R700016200 PMID: 17502367.
42. Li J. JAK-STAT and bone metabolism. JAKSTAT. 2013; 2(3):e23930. Epub 2013/09/27. PMID: 24069548; PubMed Central PMCID: PMC3772100.
43. Mukherjee A, Larson EA, Klein RF, Rotwein P. Distinct actions of akt1 on skeletal architecture and function. PLoS One. 2014; 9(3):e93040. Epub 2014/03/26. doi: 10.1371/journal.pone.0093040 PMID: 24663486; PubMed Central PMCID: PMC3963959.
44. Servet-Delprat C, Arnaud S, Jurdic P, Nataf S, Grasset MF, Soulas C, et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC immunology. 2002; 3:15. PMID: 12398794; PubMed Central PMCID: PMC134601.
45. Koh JM, Oh B, Lee JY, Lee JK, Kimm K, Park BL, et al. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2007; 22 (11):1752-8. doi: 10.1359/jbmr.070705 PMID: 17620055.
46. Itoh T, Nozawa Y, Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2- induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. The Journal of biological chemistry. 2009; 284(29):19272-9. doi: 10.1074/jbc.M109.014001 PMID: 19454767; PubMed Central PMCID: PMC2740552.
47. Chen L, Holmstrom K, Qiu W, Ditzel N, Shi K, Hokland L, et al. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem cells. 2014; 32(4):902-12. doi: 10.1002/stem.1615 PMID: 24307639.
48. Krzeszinski JY, Wei W, Huynh H, Jin Z, Wang X, Chang TC, et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature. 2014; 512(7515):431-5. Epub 2014/07/22. doi: 10.1038/nature13375 PMID: 25043055; PubMed Central PMCID: PMC4149606.
49. Plomin R, Haworth CM, Davis OS. Common disorders are quantitative traits. Nat Rev Genet. 2009; 10 (12):872-8. Epub 2009/10/28. doi: 10.1038/nrg2670 PMID: 19859063.
50. van Eijk KR, de Jong S, Boks MP, Langeveld T, Colas F, Veldink JH, et al. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics. 2012; 13:636. Epub 2012/11/20. doi: 10.1186/1471-2164-13-636 PMID: 23157493; PubMed Central PMCID: PMC3583143.
51. Coli G. To prevent the osteoporosis playing in advance. Clinical cases in mineral and bone metabolism: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. 2013; 10(2):83-5. PMID: 24133522; PubMed Central PMCID: PMC3797006.
52. Harvey N, Dennison E, Cooper C. Osteoporosis: a lifecourse approach. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2014; 29 (9):1917-25. doi: 10.1002/jbmr.2286 PMID: 24861883.
53. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ. 1991; 303(6808):961-4. Epub 1991/10/19. PMID: 1954420; PubMed Central PMCID: PMC1671323.